Goat Polyclonal ABCB5 antibody. Suitable for WB and reacts with Human samples. Cited in 7 publications. Immunogen corresponding to Synthetic Peptide within Human ATP-binding cassette sub-family B member 5 aa 450-500.
View Alternative Names
ATP-binding cassette sub-family B member 5, ABCB5 P-gp, P-glycoprotein ABCB5, ABCB5
- WB
Unknown
Western blot - Anti-ABCB5 antibody (AB77549)
Primary incubation was 1 hour.
All lanes:
Western blot - Anti-ABCB5 antibody (ab77549) at 0.3 µg/mL
All lanes:
Human skin Lysate in RIPA buffer. at 35 µg
Predicted band size: 90 kDa
Observed band size: 90 kDa
true
- WB
Unknown
Western blot - Anti-ABCB5 antibody (AB77549)
Primary incubation was 1 hour.
All lanes:
Western blot - Anti-ABCB5 antibody (ab77549) at 0.03 µg/mL
All lanes:
A431 cell lysate (in RIPA buffer) at 35 µg
Predicted band size: 90 kDa
Observed band size: 80 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ABCB5 plays an essential role in the regulation of cellular processes including development proliferation and differentiation. It is part of the ATP-binding cassette transporters which help in maintaining cellular homeostasis by exporting toxic substances out of cells. In stem cells ABCB5 maintains the undifferentiated state and protects cells from apoptosis by mediating efflux of drugs contributing to multidrug resistance.
Pathways
ABCB5 interacts with several cellular pathways involved in cell survival and drug resistance. It is closely connected with the Wnt/beta-catenin signaling pathway which regulates cell proliferation and differentiation. ABCB5 also interacts with proteins like P-glycoprotein (ABCB1) as they both participate in similar drug resistance mechanisms affecting therapeutic outcomes in cancer treatment.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Cancer drug resistance (Alhambra, Calif.) 7:29 PubMed39267923
2024
Applications
Unspecified application
Species
Unspecified reactive species
Pigment cell & melanoma research 33:112-118 PubMed31595650
2019
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 8:73 PubMed29311580
2018
Applications
Unspecified application
Species
Unspecified reactive species
Molecular pharmaceutics 11:3452-62 PubMed25115303
2014
Applications
Unspecified application
Species
Unspecified reactive species
Cancer research 72:5111-8 PubMed22865455
2012
Applications
IHC-P
Species
Human
The Journal of investigative dermatology 131:944-55 PubMed21270824
2011
Applications
Flow Cyt
Species
Human
Gastroenterology 140:344-55 PubMed20682318
2010
Applications
Flow Cyt
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com